SCHEMBL6170551

SCHEMBL6170551

Cc1noc(-c2ccc(S(N)(=O)=O)cc2)c1-c1ccc(Cl)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 6/20 0.54
CA2 P00918 6/20 0.54
CA4 P22748 4/20 0.54
CA7 P43166 3/20 0.54
MAOA P21397 1/20 0.51
MAOB P27338 1/20 0.51
PTGS2 P35354 13/20 0.50
CA9 Q16790 5/20 0.50
CA12 O43570 4/20 0.50
CA5A P35218 3/20 0.50
CA5B Q9Y2D0 3/20 0.50
CA3 P07451 2/20 0.50
CA6 P23280 2/20 0.50
CA13 Q8N1Q1 2/20 0.50
CA14 Q9ULX7 2/20 0.50
PTGS1 P23219 5/20 0.48
MT-CO2 P00403 1/20 0.48
LMNA P02545 1/20 0.48
ADRB2 P07550 1/20 0.48
ADRB1 P08588 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6170394 1.00 CA1 (0.54) CA1CA2CA4CA7MAOA
SCHEMBL6168306 0.89 CA2 (0.56) CA1CA2CA4CA7PTGS2
SCHEMBL6169868 0.89 CA2 (0.56) CA1CA2CA4CA7PTGS2
SCHEMBL6013960 0.87 PTGS2 (0.63) CA1CA2CA4CA7MAOA
SCHEMBL6169136 0.87 PTGS2 (0.63) CA1CA2CA4CA7MAOA
SCHEMBL6169214 0.86 PTGS2 (0.64) CA1CA2CA4CA7MAOA
SCHEMBL6169079 0.86 PTGS2 (0.64) CA1CA2CA4CA7MAOA
SCHEMBL6517910 0.86 CA2 (0.54) CA1CA2CA4CA7PTGS2
SCHEMBL6169441 0.86 CA2 (0.55) CA1CA2CA4CA7PTGS2
SCHEMBL6170854 0.83 KIF11 (0.57) CA1CA2CA4CA7PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1528059-A2 Substituted isoxazoles for the treatment of inflammation G.D. Searle LLC (US) 2005-05-04 EP claimed
CN-1442139-A Medicinal composition for treating inflammation SEARLE & CO (US) 2003-09-17 CN claimed
CN-1107058-C Substituted isoxazoles for the treatment of disorders SEARLE & CO (US) 2003-04-30 CN claimed
EP-1223167-A2 Substituted isoxazoles for the treatment of inflammation G.D. Searle & Co. (US) 2002-07-17 EP claimed
EP-0809636-A1 SUBSTITUTED ISOXAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1997-12-03 EP claimed
WO-1996025405-A1 SUBSTITUTED ISOXAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-08-22 WO claimed